EVAX - Evaxion Biotech A/S

QQQ $ 478.05 $ -1.55 (-0.32 %)

DIA $ 391.06 $ -2.96 (-0.75 %)

SPY $ 544.78 $ 2.09 (0.39 %)

TLT $ 94.49 $ 0.16 (0.17 %)

GLD $ 213.08 $ -1.11 (-0.52 %)

Previous Close

$ 2.81

Open

$ 2.94

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.94 - $ 2.94

52 Week Range

$ 2.26 - $ 13.82

Volume

9,066

Average Volume

Market Cap

106.49M

Beta (5Y Monthly)

$ 1.80

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Evaxion, On Patent Application for AI-Base...
06/26/2024 11:31:59

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
06/19/2024 20:30:52

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 20:31:14

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

Evaxion Announces Publication Of Data From...
06/17/2024 12:46:33

HC Wainwright & Co. Reiterates Buy on Evax...
06/04/2024 11:17:30

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

Evaxion Presents Validating Immune Data Fr...
06/03/2024 12:47:34

Evaxion's AI-designed cancer vaccine, EVX-01, triggered a specific and tumor-targeting immune response in all assayed melan...

Evaxion Biotech Q1 EPS $0.03 Beats $(0.56)...
05/28/2024 12:30:00

Evaxion Biotech (NASDAQ:EVAX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.5...

Evaxion Received A Letter From The Nasdaq ...
05/10/2024 21:03:50

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

Evaxion Biotech Files For For Offer And Sa...
05/06/2024 21:12:04

Evaxion Announces First Patient Completed ...
04/17/2024 12:09:57

HC Wainwright & Co. Reiterates Buy on Evax...
04/03/2024 10:41:18

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 16:31:06

Ladenburg Thalmann Upgrades Evaxion Biotec...
04/02/2024 15:39:13

Ladenburg Thalmann analyst Ahu Demir upgrades Evaxion Biotech (NASDAQ:EVAX) from Neutral to Buy and announces $8 price target.

Evaxion Biotech Concludes Large Non-rodent...
04/02/2024 11:08:37

Recap: Evaxion Biotech Q4 Earnings
03/27/2024 13:35:07

Evaxion's 2023 Cash And Cash Equivalents O...
03/27/2024 11:36:35

Evaxion Biotech Q4 EPS $(0.16) Beats $(1.6...
03/27/2024 11:34:12

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(1.6...

HC Wainwright & Co. Reiterates Buy on Evax...
03/20/2024 10:54:33

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

Evaxion Announces Completion of the Initia...
02/20/2024 12:32:47

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...